Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Trial of Sorafenib and Erlotinib in Patients With Refractory Solid Tumors

NCT00759928 is registered in ClinicalTrials.gov with SCRI Development Innovations, LLC as lead sponsor.

NCT NCT00759928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00759928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Trial of Sorafenib and Erlotinib in Patients With Refractory Solid Tumors
Lead sponsor
SCRI Development Innovations, LLC
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2008
Completion date
June 30, 2014
Enrollment
48 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

refractory solid tumors